D. R. Henderson

发表

Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomes.

D. Woolf, M. Williams, C. Goh, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Development of Attenuated Replication Competent Adenoviruses (ARCAs) for the Treatment of Prostate Cancer

D. R. Henderson, De-Chao Yu, D. Henderson, 2002 .

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy.

D. Yu, D. R. Henderson, Y. Chen, 2000, Human gene therapy.

Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.

Hong Zhang, M. Embry, Y. Chen, 2001, Cancer research.

VaxiPatch™, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017.

D. R. Henderson, Thomas J. Ellison, George C. Talbott, 2020, Vaccine.

Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer (*)

J. D. Miller, D. R. Henderson, Joseph D. Miller, 1996, The Journal of Biological Chemistry.

CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.

T. DeWeese, Y. Chen, D. Karpf, 2001, Cancer research.

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

H. G. van der Poel, Y. Chen, S. Piantadosi, 2001, Cancer research.

Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.

J. Simons, H. Lim, R. Rodriguez, 1997, Cancer research.

Recurrent Prostate Cancer following Radiation Therapy Selective Oncolytic Adenovirus , for the Treatment of Locally A Phase I Trial of CV 706 , a Replication-competent , PSA Updated

S. Piantadosi, T. DeWeese, U. Hamper, 2001 .

Treatment outcomes for small cell carcinoma of the bladder: results from a UK patient retrospective cohort study.

R. Huddart, V. Khoo, N. Vasudev, 2021, International journal of radiation oncology, biology, physics.

Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.

E. Huskisson, R. Grahame, F. Hart, 1974, Annals of the rheumatic diseases.

Propylthiouracil therapy: an unusual cause of antineutrophil cytoplasmic antibody associated alveolar hemorrhage.

B. Kirkham, D. R. Henderson, E. Romas, 1995, The Journal of rheumatology.

Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.

D. Yu, D. R. Henderson, G. T. Sakamoto, 1999, Cancer research.

A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.

Hong Zhang, Y. Chen, D. Yu, 2001, Cancer research.

Antitumor Efficacy without Increasing Toxicity Combination with Radiotherapy Produces Synergistic CV 706 , a Prostate Cancer-specific Adenovirus Variant , in Updated Version

T. DeWeese, D. Karpf, Ja-Kyeong Lee, 2001 .

Lack of correlation of synovial histology with joint damage in rheumatoid arthritis.

D. R. Henderson, C. Tribe, M. I. Jayson, 1975, Annals of the rheumatic diseases.

Vertical atlanto-axial subluxation in rheumatoid arthritis.

D. R. Henderson, D. Henderson, 1975, Rheumatology and rehabilitation.

Lackofcorrelation ofsynovial histology withjoint damageinrheumatoid arthritis

D. R. Henderson, C. Tribe, M. I. Jayson, 1975 .

The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts.

Y. Chen, D. Yu, D. R. Henderson, 1999, Cancer research.

Advances in Brief Antitumor Synergy of CV 787 , a Prostate Cancer-specific Adenovirus , and Paclitaxel and Docetaxel

M. Embry, Hong Zhang, J. Oh, 2001 .

Intradermal delivery of a quadrivalent cell-based seasonal influenza vaccine using an adjuvanted skin patch vaccination platform.

D. R. Henderson, Thomas J. Ellison, George C. Talbott, 2022, Vaccine.

Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma

D. Kalaitzidis, J. Terrett, D. R. Henderson, 2018, Blood.

The mechanism of interferon induction by UV-irradiated reovirus.

D. R. Henderson, W. Joklik, D. Henderson, 1978, Virology.

Histiocytic necrotising lymphadenitis in systemic lupus erythematosus.

B. Kirkham, D. R. Henderson, D. Henderson, 1992, Annals of the rheumatic diseases.

Adenovirus for Prostate Cancer Therapy Calydon Virus 764, an Attenuated Replication Competent Human Kallikrein 2 and Their Use in the Construction of Identification of the Transcriptional Regulatory Sequences

D. R. Henderson, G. T. Sakamoto, D. Henderson, 1999 .

Bilateral pleural and pericardial effusions because of mediastinal placement of a central venous catheter.

D. R. Henderson, D. Henderson, T. C. Simmons, 1991, JPEN. Journal of parenteral and enteral nutrition.